To Create a world
where medical
services
can be
accessed with
technology
anywhere, anytime

Our Mission

AIMedicine

As a supporting partner to medical practitioners throughout the world, Medmain develops and operates PidPort, an analytical system for pathological image diagnosis that makes use of Deep Learning, as well as Medteria, a specialized cloud-based service for medical students.

PidPort

PidPort is an analytical system for pathological image diagnosis that enables super-precise, prompt pathological diagnosis using our unique Deep Learning/AI-based image processing technology. PidPort also features a remote pathological diagnosis function that leverages cloud network technology.*

  • aidiagnosis
    AI Analysis

    AI-based pathological screening

    PidPort enables highly precise and instantaneous screening of pathologic tissue and cells using AI independently developed by Medmain. As an assistant to medical practitioners, the system eases one's daily workflow.*

  • テレパソロジー
    Telepathology

    Globally-linked remote pathological diagnosis

    PidPort's telepathology (remote pathological diagnosis) function enables optimal, timely pathological diagnosis requests and support via a network of medical practitioners around the world.

  • イメージセンター
    Cloud Storage

    Optimal storage space for pathologic specimens

    Digitization enables cloud-based management and storage of pathologic image data and case histories without the need to worry about deterioration or physical storage space.

  • *It is depending on the country and region, all or a certain feature are available for use. Please contact us for details.

See more
Pidport 病理診断モニター
See more

Products & Services

  • Deep Learningによる病理画像診断ソフト「PidPort」
  • 病理組織標本の高品質デジタル化クラウドストレージサービス
  • 医学生向けクラウドサービス「Medteria」

Publications & Awards

  • nict
  • japan_open_innovation
  • techcrunch
  • jstartup
  • livesharkstank
  • latitude59

Team

Medmain is a professional team composed of engineers and pathologists as well as a diverse variety of other personnel from a wide range of nationalities.

  • CEO

    Osamu Iizuka

  • Board of Director

    Masayuki Tsuneki

  • Outside Director

    Katsumasa Niki

  • Outside Director

    Shigeo Nakano

See more
See more

Office

  • Fukuoka

  • Tokyo

  • US